West Tower Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-467
Closed -$26.5K 323
2023
Q4
$26.5K Buy
467
+312
+201% +$16.3K 0.05% 265
2023
Q3
$8.44K Buy
155
+7
+5% +$415 ﹤0.01% 417
2023
Q2
$9.96K Buy
+148
New +$9.03K 0.01% 430

Other funds holding LMAT

West Tower Group's LMAT Position: Q1 2024 in Review

West Tower Group sold out of LeMaitre Vascular (LMAT) in Q1 2024, closing a stake of 467 shares — an estimated $26.5K sold.

West Tower Group first reported a position in LMAT in Q2 2023 and held it in 3 quarters. The position peaked at $26.5K in Q4 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.

  • West Tower Group reported no remaining LeMaitre Vascular position as of Q1 2024 after selling out during the quarter.
  • West Tower Group sold 467 LeMaitre Vascular shares in Q1 2024, an estimated $26.5K.
  • West Tower Group first reported a position in LeMaitre Vascular in Q2 2023 and held it in 3 quarters.
  • West Tower Group's LeMaitre Vascular position peaked at $26.5K in Q4 2023.
  • 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.

Based on West Tower Group's 13F filing for Q1 2024, filed 14 May 2024.